Bociąga-Jasik, M.; Lara, M.; Raczyńska, A.; Wizner, B.; Polański, S.; Mlicka-Kowalczyk, E.; Garlicki, A.; Sanak, M.
Effectiveness and Safety of SARS-CoV-2 Vaccination in HIV-Infected Patients—Real-World Study. Vaccines 2023, 11, 893.
https://doi.org/10.3390/vaccines11050893
AMA Style
Bociąga-Jasik M, Lara M, Raczyńska A, Wizner B, Polański S, Mlicka-Kowalczyk E, Garlicki A, Sanak M.
Effectiveness and Safety of SARS-CoV-2 Vaccination in HIV-Infected Patients—Real-World Study. Vaccines. 2023; 11(5):893.
https://doi.org/10.3390/vaccines11050893
Chicago/Turabian Style
Bociąga-Jasik, Monika, Martyna Lara, Aleksandra Raczyńska, Barbara Wizner, Stanisław Polański, Ewa Mlicka-Kowalczyk, Aleksander Garlicki, and Marek Sanak.
2023. "Effectiveness and Safety of SARS-CoV-2 Vaccination in HIV-Infected Patients—Real-World Study" Vaccines 11, no. 5: 893.
https://doi.org/10.3390/vaccines11050893
APA Style
Bociąga-Jasik, M., Lara, M., Raczyńska, A., Wizner, B., Polański, S., Mlicka-Kowalczyk, E., Garlicki, A., & Sanak, M.
(2023). Effectiveness and Safety of SARS-CoV-2 Vaccination in HIV-Infected Patients—Real-World Study. Vaccines, 11(5), 893.
https://doi.org/10.3390/vaccines11050893